The Involvement of the Mammalian Target of Rapamycin, Protein Tyrosine Phosphatase 1b and Dipeptidase 4 Signaling Pathways in Cancer and Diabetes: A Narrative Review
-
Published:2021-04-08
Issue:7
Volume:21
Page:803-815
-
ISSN:1389-5575
-
Container-title:Mini-Reviews in Medicinal Chemistry
-
language:en
-
Short-container-title:MRMC
Author:
Zhang Jiajia1,
Wu Ning1,
Shi Dayong1
Affiliation:
1. Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao, Shandong, China
Abstract
Background:
The mammalian target of rapamycin (mTOR), protein tyrosine phosphatase
1b (PTP1B) and dipeptidase 4 (DPP4) signaling pathways regulate eukaryotic cell proliferation and
metabolism. Previous researches described different transduction mechanisms in the progression of
cancer and diabetes.
Methodology:
We reviewed recent advances in the signal transduction pathways of mTOR, PTP1B
and DPP4 regulation and determined the crosstalk and common pathway in diabetes and cancer.
Results:
We showed that according to numerous past studies, the proteins participate in the signaling
networks for both diseases.
Conclusion:
There are common pathways and specific proteins involved in diabetes and cancer. This
article demonstrates and explains the potential mechanisms of association and future prospects for
targeting these proteins in pharmacological studies.
Funder
National Natural Science Foundation of China
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology,General Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献